Overview
Innovations in Cardiovascular Therapeutics 2017
Registration is closed for this activity.
Innovations in Cardiovascular Therapeutics 2017 is a comprehensive educational symposium designed to educate clinicians, physician-trainees, nurses and allied health professionals across a wide range of specialties, in the application of innovative therapies for cardiovascular disease. The distinguished faculty for this event include many of the foremost clinicians at the University of Chicago Heart and Vascular Center as well as internationally recognized guest faculty. Through focused presentations, panel discussion, and interactive dialogue; participants will gain both broad perspective and detailed insights into medical, procedural, and surgical therapies for complex cardiovascular disease. Registration fees include attendance to all educational events in addition to meals, refreshments, and both evening events sponsored by Innovations in Cardiovascular Therapeutics 2017.
Note, fellows will be charged a $50 fee upon registration. The $50 will be refunded once you check-in at the registration desk. Please allow at least two weeks for refund processing.
Full refunds will only be given prior to August 14, 2017. After August 14, refunds will be provided, less a $30 administrative processing fee. All refunds should be submitted to mforcier@achlcme.org.
Note, fellows will be charged a $50 fee upon registration. The $50 will be refunded once you check-in at the registration desk. Please allow at least two weeks for refund processing.
Full refunds will only be given prior to August 14, 2017. After August 14, refunds will be provided, less a $30 administrative processing fee. All refunds should be submitted to mforcier@achlcme.org.
This symposium is designed for general cardiologists, internists, hospitalists, family practitioners, cardiothoracic and vascular surgeons, electrophysiologists and interventional cardiologists, as well as nurses, technologists and other allied health care professionals who treat and manage heart disease.
This two-day symposium is designed to educate attendees on novel therapeutics and evidence-based
management, across the spectrum of cardiovascular disease. Additionally, cutting edge therapies in interventional cardiology, structural heart interventions, complex arrhythmia and lead management, advanced heart failure and cardiac transplantation, cardiac imaging, preventive and molecular cardiology, and cardiac and vascular surgery will be discussed. The distinguished faculty for this event include many of the foremost clinicians at the University of Chicago Heart and Vascular Center, as well as internationally recognized faculty.
management, across the spectrum of cardiovascular disease. Additionally, cutting edge therapies in interventional cardiology, structural heart interventions, complex arrhythmia and lead management, advanced heart failure and cardiac transplantation, cardiac imaging, preventive and molecular cardiology, and cardiac and vascular surgery will be discussed. The distinguished faculty for this event include many of the foremost clinicians at the University of Chicago Heart and Vascular Center, as well as internationally recognized faculty.
Upon completion of this educational activity, participants will be better able to:
• Outline current and emerging therapies for the treatment of valvular heart disease, with a focus on transcatheter, robotic, and complex surgical techniques.
• Discuss new minimally invasive and percutaneous therapies for patients with complex coronary disease including patients with multivessel disease, chronic total occlusions and severely impaired LV systolic dysfunction
• Review recent advances in the medical and mechanical management of heart failure patients across the progression of symptoms and stages with additional targeted discussion on the use of mechanical circulatory support and innovative defibrillation and pacing strategies such as cardiac resynchronization therapy (CRT) and His-bundle pacing (HBP).
• Describe the role echocardiography plays in diagnosis and guiding therapies across multiple disciplines within cardiology, including emerging fields such as cardio-oncology.
• Explain the management of acute cardiovascular syndromes such as pulmonary embolism, hospitalized heart failure, and myocardial infarction, and how processes and new technologies can help improve outcomes in these patients.
• Distinguish between cardiovascular imaging modalities and their clinical application in disease assessment, risk stratification and treatment decisions
• Summarize strategies and innovations designed to diagnose and treat heart failure subtypes such as amyloidosis and the stage D patient.
• Interpret the role of new pharmacotherapies and guidelines for the management of hyperlipidemia and prevention of cardiovascular events.
• Discuss strategies for streamlining cardiovascular healthcare delivery and additional opportunities to optimize cost efficiencies.
• Outline current and emerging therapies for the treatment of valvular heart disease, with a focus on transcatheter, robotic, and complex surgical techniques.
• Discuss new minimally invasive and percutaneous therapies for patients with complex coronary disease including patients with multivessel disease, chronic total occlusions and severely impaired LV systolic dysfunction
• Review recent advances in the medical and mechanical management of heart failure patients across the progression of symptoms and stages with additional targeted discussion on the use of mechanical circulatory support and innovative defibrillation and pacing strategies such as cardiac resynchronization therapy (CRT) and His-bundle pacing (HBP).
• Describe the role echocardiography plays in diagnosis and guiding therapies across multiple disciplines within cardiology, including emerging fields such as cardio-oncology.
• Explain the management of acute cardiovascular syndromes such as pulmonary embolism, hospitalized heart failure, and myocardial infarction, and how processes and new technologies can help improve outcomes in these patients.
• Distinguish between cardiovascular imaging modalities and their clinical application in disease assessment, risk stratification and treatment decisions
• Summarize strategies and innovations designed to diagnose and treat heart failure subtypes such as amyloidosis and the stage D patient.
• Interpret the role of new pharmacotherapies and guidelines for the management of hyperlipidemia and prevention of cardiovascular events.
• Discuss strategies for streamlining cardiovascular healthcare delivery and additional opportunities to optimize cost efficiencies.
Swissôtel Chicago
323 E Upper Wacker Dr
Chicago, IL 60601 USA
Click here to view location map
Phone: 312-565-0565
323 E Upper Wacker Dr
Chicago, IL 60601 USA
Click here to view location map
Phone: 312-565-0565
Friday, October 20, 2017 | ||
7:00 – 9:00 pm | Welcome, Registration & Exhibit Hall: Wine and Cheese Reception | |
Saturday, October 21, 2017 | ||
HOT TOPICS IN CARDIOVASCULAR MEDICINE | ||
7:00 – 7:45 am | Registration and Breakfast | |
7:45 – 8:00 am | Welcome and Introduction | Sharon O'Keefe and James Liao, MD |
8:00 – 8:45 am | Keynote Address: The epidemic of CVD in the developing world: Global implications | Bernard Gersh, MB, ChB, DPhil |
8:45 – 9:15 am | Surgical options for advanced heart failure | Valluvan Jeevanandam, MD |
9:15 – 9:45 am | Lipid Management in the Diabetic Patient | Matthew Sorrentino, MD |
9:45 – 10:15 am | BREAK & EXHIBITS: COFFEE & SNACKS | |
10:15 – 10:45 am | Applying lean process to TAVR | Gregory J. Mishkel, MD |
10:45 – 11:15 am | Management strategies of the cardio-oncology Patient | Jeanne DeCara, MD |
11:15 – 11:45 am | Robotic cardiac surgery at University of Chicago Medicine: Taking it to the next level | Husam Balkhy, MD |
11:45 - 12:15 pm | Advanced imaging options and application for complex diseases | Amit Patel, MD |
12:15 – 1:30 pm | LUNCH and PRODUCT THEATER | |
INTERVENTIONAL AND SURGICAL CV THERAPEUTICS | ||
1:30 – 2:00 pm | Novel targets for radiofrequency ablation | Roderick Tung, MD |
2:00 – 2:30 pm | Diagnosis and treatment of aortic disease | Ross Milner, MD |
2:30 – 3:00 pm | Pulmonary Embolus Response Team (PERT) program and development | Jonathan Paul, MD |
3:00 – 3:30 pm | Advanced treatment options for the patient with heart failure | Gabriel Sayer, MD |
3:30 – 4:00 pm | BREAK & EXHIBITS: COFFEE & SNACKS | |
4:00 – 4:30 pm | Surgical options for complex valvular disease | Takeyoshi Ota, MD, PhD |
4:30 – 5:00 pm | Options for cardiac resynchronization | Gaurav Upadhyay, MD |
5:00 – 5:30 pm | State of art in percutaneous coronary revascularization | Sandeep Nathan, MD, MSc |
6:30 – 9:30 pm | Dinner Reception | |
Sunday, October 22, 2017 | ||
The multi-dimensional approach to complex heart care | ||
7:00 – 8:00 am | Registration and Breakfast | |
8:00 – 8:30 am | What's new in valvular heart disease? | John Blair, MD |
8:30 – 9:00 am | STEMI management 2017 – Improving the process | Atman Shah, MD |
9:00 – 10:00 am | Challenging cases discussion | Fellow and Faculty Panel |
10:00 – 10:30 am | BREAK & EXHIBITS: COFFEE & SNACKS | |
10:30 – 11:00 am | Amyloid diagnosis and management options | Nitasha Sarswat, MD |
11:00 – 11:30 am | Echocardiography today: A disruptive technology? | Roberto Lang, MD |
11:30 – 12:00 pm | Inflammation and atherosclerosis: A Therapeutic Frontier | Francis Alenghat, MD, PhD |
12:00 – 12:30 pm | Novel interventions to prevent heart failure readmissions | Corey Tabit, MD |
12:30 – 1:30 pm | Lunch & Adjourn |
REGISTRATION CANCELLATION POLICY:
Full refunds will only be given prior to August 14, 2017. After August 14, refunds will be provided, less a $30 administrative processing fee. All refunds should be submitted to mforcier@achlcme.org.
Full refunds will only be given prior to August 14, 2017. After August 14, refunds will be provided, less a $30 administrative processing fee. All refunds should be submitted to mforcier@achlcme.org.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number 14803 for 11.25 contact hours.